"Role of Inhaled Amikacin in Preventing Ventilator-Associated Pneumonia: A Clinical Study"

Abstract

Ventilator-associated pneumonia (VAP) remains the most frequent presentation of hospital
acquired lower respiratory tract infections, significantly contributing to morbidity and mortality 
in intensive care units (ICUs). VAP predominantly affects patients undergoing invasive 
mechanical ventilation, with microaspirations